The Latest With The Marijuana Rescheduling Hearings

DEA's Own Pharmacologist Undercuts Marijuana Rescheduling Order

"Government's Own Scientific Expert Testified Marijuana Failed DEA's Traditional Medical Use Standard, Lacked Reproducible Chemistry, and That HHS Omitted Critical Public Health Findings" stated Duane Boise CEO MMJ International Holdings.

The Latest With The Marijuana Rescheduling Hearings

The Fresh Toast - The latest with the marijuana rescheduling hearings reveals one-sided testimony and growing controversy over the hearing..

Update DEA Hearing July 6: Harvard Expert Testifies State Dispensary Cannabis Does Not Meet Pharmaceutical Standards

DOJ Says the Controlled Substances Act Protects Legitimate Scientific Research. MMJ Says the Government Should Start Treating It That Way.

SAM Witness Acknowledges Marijuana Fits Schedule III Definition During DEA Rescheduling Hearing

The Marijuana Herald - Marijuana news and information A key witness for Smart Approaches to Marijuana (SAM), one of the nation’s leading anti-legalization organizations, acknowledged during the Drug Enforcement Administration’s (DEA) ongoing marijuana rescheduling hearing that cannabis fits the legal definition of a Schedule III controlled substance. During a cross-examination by the DEA, Dr. Bertha K. Madras, a Harvard Medical School psychiatry…

Most Marijuana Consumers Don’t Believe Trump Administration Will Complete Rescheduling This Year, Poll Shows

As a hearing on Trump administration's federal marijuana rescheduling proposal proceeds this month, a new poll shows that most cannabis consumers aren't optimistic that reform will be fully implemented by the end of the year. Acting Attorney General Todd Blanche in April issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I o…

Musings from the DEA Schedule III hearing [GUEST POST]

Editor’s note: This article was written by my friend and colleague, Gary Kaminsky. Gary is representing Corey A. Burchman, MD, in the DEA hearing on the notice of proposed rulemaking to transfer marijuana from schedule I to schedule III of the Controlled Substances Act. Dr. Burchman is a longtime respected cannabis advocate. In this article, Gary […]